Oslo, Norway – December 2024 – Aker BioMarine has named Jaroslava Juricova-Olsen as Chief Marketing Officer for its Human Health Ingredients (HHI) segment. With extensive experience in marketing and brand development, she will help drive the company’s mission to improve human health.
Juricova-Olsen joins Aker BioMarine from Salmon Brands (SALMA), where she served as Marketing Director, leading efforts to drive consumer awareness and product innovation with a focus on sustainability and quality. Her experience in connecting brands with consumers through education and innovation aligns seamlessly with Aker BioMarine’s mission and vision.
“The krill omega-3 industry offers tremendous potential to improve global health, and Aker BioMarine’s innovative products align perfectly with the increasing demand for sustainable, high-quality health solutions,” Juricova-Olsen stated. “I am passionate about empowering consumers with knowledge about the health benefits of these products, enabling them to make informed decisions that contribute to their well-being. I look forward to working with the Aker BioMarine team to expand the reach and impact of our offerings.”
Bringing new products to market
In her new role, Juricova-Olsen will oversee marketing strategies for HHI’s portfolio, including FloraMarine, a plant-based DHA omega-3 ingredient, and Lysoveta, a brain health supplement. Her focus will be on driving growth and ensuring that Aker BioMarine’s products deliver both health benefits and sustainability to global markets.
Simon Seward, CEO of Human Health Ingredients at Aker BioMarine, welcomed Juricova-Olsen’s appointment. “Jaroslava’s extensive experience in understanding diverse consumer needs across global markets, is invaluable as we adapt our strategies to meet local demands. Her expertise in driving marketing efforts on an international scale will help us connect with consumers and effectively communicate the health benefits of products like Superba, FloraMarine and Lysoveta With the krill oil market projected to grow at a compound annual growth rate of 10.5% from 2023 to 2033, reaching approximately USD 2.7 billion, her leadership will be instrumental in advancing Aker BioMarine’s vision for global growth and innovation.”
Juricova-Olsen’s academic background includes a Master of Science in Business from BI Norwegian Business School and a Master’s degree in International Trade from the Prague University of Economics and Business. She also brings valuable experience as a former Marketing Director at Orkla Health where she focused on category development and brand strategy.
This appointment reflects Aker BioMarine’s commitment to strengthening its leadership team to support the company’s vision of improving human health while contributing to a more sustainable future.
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE